Application no. and date | 11745672.3 (espacenet) (Federated) (European Patent Register), 20110809 | Patent/reg. no. and date | DK/EP 2603523, 20160127 | Publication date | 20130619 | Priority no. and date | US 373026 P, 20100812 | EP pub. no. and date |
EP 2603523 20130619 | Effective date | | Applicant/owner | Eli Lilly and Company, Lilly Corporate Center
Indianapolis, IN 46285, US | Applicant ref. no. | P81600348DK00E | Inventor | LU, Jirong, c/o Eli Lilly and Company P.O. Box 6288
Indianapolis Indiana 46206-6288, US, TANG, Ying, c/o Eli Lilly and Company P.O. Box 6288
Indianapolis Indiana 46206-6288, US, DEMATTOS, Ronald Bradley, c/o Eli Lilly and Company P.O. Box 6288
Indianapolis Indiana 46206-6288, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 39/395 (2006.01) , A61P 25/28 (2006.01) , C07K 16/18 (2006.01) , G01N 33/577 (2006.01) | Title | ANTI-N3pGlu-AMYLOIDBETAPEPTIDANTISTOFFER OG ANVENDELSER DERAF | Int. application no. | US2011046994 | Int. publication no. | WO2012021469 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|